跳至主要内容
临床试验/ITMCTR2100004445
ITMCTR2100004445招募中未知

A randomized double blind placebo parallel controlled study on the effect of decoction of Caulis Lonicerae on the plaque fiber cap thickness in patients with carotid atherosclerosis

Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • 1. The patients with carotid atherosclerotic plaques were diagnosed by color Doppler ultrasound;
  • 2. hsCRP >= 2 mg/L;
  • 3. Patients between 40 and 80 years old, regardless of gender;
  • 4. Patients who can take medicine for a long time;
  • 5. Patients who have informed consent and signed the informed consent.

排除标准

  • 1.Acute or subacute hemorrhage in plaque;
  • 2.Plaque is calcified and fibrotic;
  • 3.Can not do MRI(such as carrying a pacemakerdenturecardiac stent);
  • 4.Patients with active ulcers and bleeding tendency who take anticoagulants (such as warfarin) for a long time; 5.Patients are using dual antiplatelet drugs;
  • 6.Patients with serious arrhythmia, atrial fibrillation and heart failure;
  • 7.Patients with severe liver, kidney, hematopoietic system, endocrine system, respiratory system, hypertension, infectious and non infectious inflammation, immune related and other primary diseases, whose liver function is more than 1.5 times higher than the upper limit of the normal value, and whose Cr is higher than the normal value;
  • 8.Any other life-threatening or serious disease that cannot be treated for 12 months and thus affects the evaluation results;
  • 9.Pregnant or lactating women, women with a recent pregnancy plan;
  • 10.Patients with allergic constitution;
  • 11.Other diseases or psychosis that may limit efficacy evaluation or patient follow-up in the opinion of researchers;
  • 12.Patients who have participated in clinical trials of other drugs in the past 4 weeks.

研究者

相似试验